Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs

July 14, 2024 3 Comments

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Leqembi Launched in China to Fight Alzheimer’s

July 3, 2024 No Comments

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Woman caring for her mother with dementia

Getting Dementia Patients to Take Their Meds

June 25, 2024 No Comments

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

May 16, 2024 No Comments

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

In the most difficult of moments, kindness helps and reassures.

Thought of the Week: Kindness Heals, Reassures

February 12, 2026

In the most difficult moments, Kindness heals and reassures.

Doctor Describing 4 Common Types of Dementia

The Four Most Common Types of Dementia — and Why Early Signs Matter

February 11, 2026

Why early warning signs matter more than most people realize.

Senior-ER Improves Treatment for Elders

February 10, 2026

Hospital stays with dementia should focus on elder safety. See a special ER for seniors, equipped with brilliant features that speed comfort and care to this population.

Most Popular Stories

My Forgetfulness: Alzheimer’s or Normal Aging?

People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.

Financial Problems Can Signal Dementia Onset

Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.

Curing Alzheimer’s by Fixing Proteins, Not Clearing Them

Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.

Can Alzheimer’s Be Treated with Iron-Modifying Drugs?

Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.